Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  World Bank Report: China Must Reform its Healthcare Delivery
  Aspen Pharma Building China Presence for its Generic Drug Portfolio
  Jilin Zixin Pharma to Pay $42 Million for Majority Stake in US Genome Mapping Company
  China to Test CRISPR-Edited Cells in Lung Cancer
  Sinopharm Revises Plan to Reform its State-Owned Enterprise Structure
  China Resources Buys Majority Stake in GenesisCare, a $1.3 Billion Australian Healthcare Chain
  Hisun Pharma In-licenses China Rights to mAb Brain Cancer Candidate
  GSK's Cervarix is First HPV Vaccine Approved for China Use
  Genexine of South Korea Raises $70 Million for Novel Drug Portfolio
  DiaMedica Raises $4 Million from Fosun Pharma and SK Group
 
Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors